Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Star
6483.0000
-55.00
(
-0.84
%)
NSE
May 23, 2025
15:31 PM
New 52W High in past week
Volume:
224.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
04 Feb 2023
6483.00
-0.84%
Divi's Labs (HOLD): Big miss on revenue and margins
Hold:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3200
Target
BOB Capital Markets Ltd.
Q3 disappoints as revenue/PAT of Rs 17bn/Rs 3bn missed consensus by 12%/38%
Divi's Laboratories Ltd. is trading above all available SMAs
More from Divi's Laboratories Ltd.
Recommended
Five Interesting Stocks Today - May 23, 2025
The Baseline |
23 May 2025, 05:22PM
Market closes higher, BEML's Q4 net profit grows 12% YoY to Rs 287.6 crore
Trendlyne Marketwatch |
23 May 2025, 04:07PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022